Clinical trials
Withdrawn Phase 3 Obesity trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 2 |
| 2015 | 1 |
| 2022 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Axel Brandes | 1 |
| Canadian Center for Functional Medicine | 1 |
| Eurofarma Laboratorios S.A. | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Neuropsychiatric Research Institute, Fargo, North Dakota | 1 |
| Novo Nordisk A/S | 1 |
| Prism Health North Texas | 1 |
| University of Minnesota | 1 |
| University of Pennsylvania | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 9 |
| Overweight | 3 |
| Acquired Immunodeficiency Syndrome | 1 |
| Atrial Fibrillation | 1 |
| Binge-Eating Disorder | 1 |
| Body Weight | 1 |
| Body Weight Changes | 1 |
| Metabolic Syndrome | 1 |
| Pediatric Obesity | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.